de Vries EGE - Search Results

1

⁸⁹Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE. Bensch F, et al. Among authors: de crespigny a, de vries ege. Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478423 Clinical Trial.

2

JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.

Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C. Fokkema E, et al. Biochem Pharmacol. 2002 Jun 1;63(11):1989-96. doi: 10.1016/s0006-2952(02)00983-8. Biochem Pharmacol. 2002. PMID: 12093475

3

An oncological view on the blood-testis barrier.

Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. Bart J, et al. Lancet Oncol. 2002 Jun;3(6):357-63. doi: 10.1016/s1470-2045(02)00776-3. Lancet Oncol. 2002. PMID: 12107023 Review.

4

Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics.

Maring JG, Piersma H, van Dalen A, Groen HJ, Uges DR, De Vries EG. Maring JG, et al. Cancer Chemother Pharmacol. 2003 Feb;51(2):167-73. doi: 10.1007/s00280-002-0535-2. Epub 2002 Nov 30. Cancer Chemother Pharmacol. 2003. PMID: 12647019

5

Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC.

Dodde WI, Maring JG, Hendriks G, Wachters FM, Groen HJ, de Vries EG, Uges DR. Dodde WI, et al. Ther Drug Monit. 2003 Aug;25(4):433-40. doi: 10.1097/00007691-200308000-00003. Ther Drug Monit. 2003. PMID: 12883225

6

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.

Spierings DC, de Vries EG, Timens W, Groen HJ, Boezen HM, de Jong S. Spierings DC, et al. Clin Cancer Res. 2003 Aug 15;9(9):3397-405. Clin Cancer Res. 2003. PMID: 12960128

7

Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.

Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, de Vries EG, Hendrikse NH. Bart J, et al. Neuroimage. 2003 Nov;20(3):1775-82. doi: 10.1016/s1053-8119(03)00405-1. Neuroimage. 2003. PMID: 14642487

8

The role of apoptosis-related genes in non-small-cell lung cancer.

Fokkema E, Groen HJ, Meijer C, Timens W, de Jong S, de Vries EG. Fokkema E, et al. Clin Lung Cancer. 2002 Nov;4(3):174-82. doi: 10.3816/clc.2002.n.025. Clin Lung Cancer. 2002. PMID: 14706167

9

Preclinical characterisation of 111In-DTPA-trastuzumab.

Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG. Lub-de Hooge MN, et al. Br J Pharmacol. 2004 Sep;143(1):99-106. doi: 10.1038/sj.bjp.0705915. Epub 2004 Aug 2. Br J Pharmacol. 2004. PMID: 15289297 Free PMC article.

10

The dilemma of the strive for apoptosis in oncology: mind the heart.

Perik PJ, de Vries EG, Gietema JA, van der Graaf WT, Sleijfer DT, Suurmeijer AJ, van Veldhuisen DJ. Perik PJ, et al. Crit Rev Oncol Hematol. 2005 Feb;53(2):101-13. doi: 10.1016/j.critrevonc.2004.10.001. Crit Rev Oncol Hematol. 2005. PMID: 15661561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page